medRxiv PreprintsInternational17 November 2026
Multidrug-Resistant Tuberculosis Rates Among High-Risk Populations in Brazil: An Analysis from 2001 to 2021
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Multidrug-Resistant Tuberculosis (MDR-TB) represents a global public health threat, with a rising prevalence, particularly among vulnerable populations. This cross-sectional study analyzed MDR-TB notifications in Brazil from 2001 to 2021, using data from DATASUS, and stratified by periods and risk groups (HIV-positive individuals, smokers, drug users, healthcare workers, incarcerated individuals, and people experiencing homelessness). Descriptive analyses and parametric statistical tests (ANOVA and Tukey, p less than 0.05) were applied. A significant increase in cases was observed across all g
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.